Literature DB >> 25204604

β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.

Jianying Li1, An Liu2, Yili Wang3.   

Abstract

BACKGROUND: β-Elemene, a novel antitumor plant drug extracted from the traditional Chinese medicinal herb Zedoary, has been shown to be effective against a wide variety of tumors. Recent studies have indicated that β-elemene can inhibit the growth of lung cancer cells; however, the exact mechanism of β-element's action in lung cancer remains largely unknown. In the present study, the antitumor effect of β-elemene on human lung cancer cells and the mechanism involved has been investigated.
METHODS: The inhibitory effects of β-elemene on cell growth were measured by Trypan Blue exclusion and MTT assay. Flow cytometric analysis was used to detect the cells' apoptotic rate. The expression of P53 mRNA and protein were measured by RT-PCR and Western blot analysis, respectively. Exosomes were isolated by differential centrifugation steps and analyzed by electron microscopy and western blotting. P53 knockdown cells were established through transfection with P53 siRNA. To investigate the effect of β-elemene on the tumor growth in vivo, a Xenograft nude mouse model was established by injecting the A549 cells into the back of a BABL/c nude mouse.
RESULTS: β-Elemene markedly inhibited growth and induced apoptosis in lung cancer cells. The levels of the anti-apoptotic genes Bcl-2 and Bcl-xl in A549 cells decreased, while expression of P53 and production of exosomes increased after β-elemene treatment. Further siRNA studies suggested that the effect of β-elemene on A549 cells is dependent on P53 expression. Exosomes derived from A549 cultured with a human lung cancer cell line exhibited decreased tumor cell proliferation. The in vivo study demonstrated that β-elemene inhibited tumor growth, and up-regulated the expression of P53 and the release of exosome.
CONCLUSION: Our results demonstrated β-elemene acts on lung cancer cells in a P53 dependent manner and exosomes are involved in the regulation of cell proliferation.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bcl-2; Bcl-xl; Exosome; Lung cancer; P53; β-Elemene

Mesh:

Substances:

Year:  2014        PMID: 25204604     DOI: 10.1016/j.lungcan.2014.08.015

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.

Authors:  Chengsong Cao; Qun Wang; Yong Liu
Journal:  Drug Des Devel Ther       Date:  2019-04-05       Impact factor: 4.162

2.  Transferrin-functionalised microemulsion co-delivery of β-elemene and celastrol for enhanced anti-lung cancer treatment and reduced systemic toxicity.

Authors:  Qian Zhang; Xin Tian; Xiufeng Cao
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 3.  The roles and implications of exosomes in sarcoma.

Authors:  Li Min; Jacson Shen; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

4.  Volatile Oil of Acori Graminei Rhizoma-Induced Apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells.

Authors:  Lu Chen; Zhuyun Jiang; Hui Ma; Ling Ning; Hongdan Chen; Li Li; Hongyi Qi
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 5.  [Research Progress of Exosomes in Lung Cancer Diagnosis and Treatment].

Authors:  Hongbo Zou; Hong Wu; Chuan Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

6.  The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.

Authors:  Kun Zou; Caigang Liu; Zhuo Zhang; Lijuan Zou
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

Review 7.  Tumor-derived exosomes in cancer progression and treatment failure.

Authors:  Shaorong Yu; Haixia Cao; Bo Shen; Jifeng Feng
Journal:  Oncotarget       Date:  2015-11-10

8.  Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics.

Authors:  Atefe Abak; Alireza Abhari; Sevda Rahimzadeh
Journal:  PeerJ       Date:  2018-05-29       Impact factor: 2.984

Review 9.  Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.

Authors:  Bingtao Zhai; Yiying Zeng; Zhaowu Zeng; Nana Zhang; Chenxi Li; Yijun Zeng; Yu You; Shuling Wang; Xiabin Chen; Xinbing Sui; Tian Xie
Journal:  Int J Nanomedicine       Date:  2018-10-10

10.  Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer.

Authors:  Fang Zheng; Qing Tang; Xiao-Hua Zheng; JingJing Wu; HaiDing Huang; Haibo Zhang; Swei Sunny Hann
Journal:  Exp Mol Med       Date:  2018-09-12       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.